AKT1 and ovarian cancer: The latest research on Sch A reveals that Sch A has a good growth inhibitory effect on human breast and ovarian cancer cells, and that its antitumor molecular mechanism may be related to ER stress, Wnt/β-catenin and PI3K/Akt signaling pathways [18,19].